MATRIX LABS: Abbott’s Kaletra(R) Patent Suit Remains Stayed
March 28, 2011
Abbott Laboratories’ patent infringement suit against Matrix Laboratories, Inc., Matrix Laboratories, Ltd., and Mylan, Inc. relating to Kaletra(R) remains stayed.
Abbott is seeking to enforce its patent rights relating to ritonavir/lopinavir…